Differential crosstalk between P2X7 and arachidonic acid in activation of mitogen-activated protein kinases

Neurochemistry International

Volumn 53, Issue 6-8, 2008, Pages 255-262

  Barbieri, Raffaella ^a   Alloisio, Susanna ^a   Ferroni, Stefano ^b   Nobile, Mario ^a  

^a CNR   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Arachidonic acid; Cultured astroglia; MAP kinases; P2X7 purinoceptors; Phosphorylation

Indexed keywords

2',3' O (4 BENZOYL)BENZOYL ADENOSINE TRIPHOSPHATE; ARACHIDONIC ACID; LIPOXYGENASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PROSTAGLANDIN SYNTHASE INHIBITOR; PURINERGIC P2X7 RECEPTOR; PURINERGIC RECEPTOR STIMULATING AGENT; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL CULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT;

ADENOSINE TRIPHOSPHATE; AFFINITY LABELS; ANIMALS; ANIMALS, NEWBORN; ARACHIDONIC ACID; ASTROCYTES; CELL LINE; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ENCEPHALITIS; HUMANS; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; RATS; RECEPTOR CROSS-TALK; RECEPTORS, PURINERGIC P2; TRANSFECTION;

RATTUS;

EID: 56349103979     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2008.05.001     Document Type: Article

References (47)

1. Alexander L.D., Cui X.L., Falck J.R., and Douglas J.G. Arachidonic acid directly activates members of the mitogen-activated protein kinase superfamily in rabbit proximal tubule cells. Kidney Int. 59 (2001) 2039-2053
2. Alloisio S., Aiello R., Ferroni S., and Nobile M. Potentiation of native and recombinant P2X7-mediated calcium signaling by arachidonic acid in cultured cortical astrocytes and human embryonic kidney 293 cells. Mol. Pharmacol. 69 (2006) 1975-1983
3. 2+ influx. Biochem. J. 374 (2003) 51-61
4. Berenbaum F., Humbert L., Bereziat G., and Thirion S. Concomitant recruitment of ERK1/2 and p38 MAPK signalling pathway is required for activation of cytoplasmic phospholipase A2 via ATP in articular chondrocytes. J. Biol. Chem. 278 (2003) 13680-13687
5. Bradford M.D., and Soltoff S.P. P2X7 receptors activate protein kinase D and p42/p44 mitogen-activated protein kinase (MAPK) downstream of protein kinase C. Biochem. J. 366 (2002) 745-755
6. Brambilla R., Burnstock G., Bonazzi A., Ceruti S., Cattabeni F., and Abbracchio M.P. Cyclo-oxygenase-2 mediates P2Y receptor-induced astrogliosis. Br. J. Pharmacol. 126 (1999) 563-567
7. Brambilla R., and Abbracchio M.P. Modulation of cyclooxygenase-2 and brain reactive astrogliosis by purinergic P2 receptors. Ann.NY Acad.Sci. 939 (2001) 54-62
8. Bu X., Huang P., Qi Z., Zhang N., Han S., Fang L., and Li J. Cell type-specific activation of p38 MAPK in the brain regions of hypoxic preconditioned mice. Neurochem. Int. 51 (2007) 459-466
9. Chang L.C., and Wang J.P. Signal transduction pathways for activation of extracellular signal-regulated kinase by arachidonic acid in rat neutrophils. J. Leukoc. Biol. 69 (2001) 659-665
10. Duan S., Anderson C.M., Keung E.C., Chen Y., Chen Y., and Swanson R.A. P2X7 receptor-mediated release of excitatory amino acids from astrocytes. J. Neurosci. 23 (2003) 1320-1328
11. English J.M., and Cobb M.H. Pharmacological inhibitors of MAPK pathways. Trends Pharmacol. Sci. 23 (2002) 40-45
12. Fa M., Diana A., Carta G., Cordeddu L., Melis M.P., Murru E., Sogos V., and Banni S. Incorporation and metabolism of c9,t11 and t10,c12 conjugated linoleic acid (CLA) isomers in rat brain. BBA 1736 (2005) 61-66
13. Farooqui A.A., Horrocks L.A., and Farooqui T. Modulation of inflammation in brain: a matter of fat. J. Neurochem. 101 (2007) 577-599
14. Ferroni S., Marchini C., Schubert P., and Rapisarda C. Two distinct inwardly rectifying conductances are expressed in long-term dibutyryl-cyclic-AMP treated rat cultured cortical astrocytes. FEBS Lett. 367 (1995) 319-325
15. Fields R.D., and Burnstock G. Purinergic signalling in neuron-glia interactions. Nat. Rev. Neurosci. 7 (2006) 423-436
16. Gendron F.P., Neary J.T., Theiss P.M., Sun G.Y., Gonzalez F.A., and Weisman G.A. Mechanisms of P2X7 receptor-mediated ERK1/2 phosphorylation in human astrocytoma cells. Am. J. Physiol. Cell Physiol. 284 (2003) 571-581
17. Halassa M.M., Fellin T., Takano H., Dong J.H., and Haydon P.G. Synaptic islands defined by the territory of a single astrocyte. J. Neurosci. 27 (2007) 6473-6477
18. Hamanoue M., Sato K., and Takamatsu K. Inhibition of p38 mitogen-activated protein kinase-induced apoptosis in cultured mature oligodendrocytes using SB202190 and SB203580. Neurochem. Int. 51 (2007) 16-24
19. Hassan S., and Carraway R.E. Involvement of arachidonic acid metabolism and EGF receptor in neurotensin-induced prostate cancer PC3 cell growth. Regul. Pep. 133 (2006) 105-114
20. Humphreys B.D., Rice J., Kertesy S.B., and Dubyak G.R. Stress-activated protein kinase/JNK activation and apoptotic induction by the macrophage P2X7 nucleotide receptor. J. Biol. Chem. 275 (2000) 26792-26798
21. Jacques-Silva M.C., Rodnight R., Lenz G., Liao Z., Kong Q., Tran M., Kang Y., Gonzalez F.A., Weisman G.A., and Neary J.T. P2X7 receptors stimulate AKT phosphorylation in astrocytes. Br. J. Pharmacol. 141 (2004) 1106-1117
22. Kinouchi H., Imaizumi S., Yoshimoto T., Yamamoto H., and Mo-tomiya M. Changes in polyphosphoinositides, lysophos-pholipid, and free fatty acids in transient cerebral ischemia of rat brain. Mol. Chem. Neuropathol. 12 (1990) 215-228
23. Lambrecht G. Agonists and antagonists acting at P2X receptors: selectivity profiles and function implications. Naunyn-Schmiedeberg's Arch. Pharmacol. 362 (2000) 340-350
24. Leslie C.C. Properties and regulation of cytosolic phospholipase A2. J. Biol. Chem. 272 (1997) 16709-16712
25. Le Stunff H., Auger R., Kanellopoulos J., and Raymond M.N. The Pro-451 to Leu polymorphism within the C-terminal tail of P2X7 receptor impairs cell death but not phospholipase D activation in murine thymocytes. J. Biol. Chem. 279 (2004) 16918-16926
26. Li J., Wang G., Wang C., Zhao Y., Zhang H., Tan Z., Song Z., Ding M., and Deng H. MEK/ERK signaling contributes to the maintenance of human embryonic stem cell self-renewal. Differentiation 75 (2007) 299-307
27. Liu J., Yin F., Zheng X., Jing J., and Hu Y. Geniposide, a novel agonist for GLP-1 receptor, prevents PC12 cells from oxidative damage via MAP kinase pathway. Neurochem. Int. 51 (2007) 361-369
28. Mitchell F.M., Russell M., and Johnson G.L. Differential calcium dependence in the activation of c-Jun kinase and mitogen-activated protein kinase by muscarinic acetylcholine receptors in rat 1a cells. Biochem. J. 309 (1995) 381-384
29. Maragakis N.J., and Rothstein J.D. Mechanisms of disease: astrocytes in neurodegenerative disease. Nat. Clin. Pract. Neurol. 2 (2006) 679-689
30. Nobile M., Monaldi I., Alloisio S., Cugnoli C., and Ferroni S. ATP-induced, sustained calcium signalling in cultured rat cortical astrocytes: evidence for a non-capacitative, P2X7-like-mediated calcium entry. FEBS Lett. 538 (2003) 71-76
31. North R.A., and Surprenant A. Pharmacology of cloned P2X receptors. Ann. Rev. Pharmacol. Toxicol. 40 (2000) 563-580
32. North R.A. Molecular physiology of P2X receptors. Physiol. Rev. 82 (2002) 1013-1067
33. Ono K., and Han J. The p38 signal transduction pathway: activation and function. Cell Signal. 12 (2000) 1-13
34. Potucek Y.D., Crain J.M., and Watters J.J. Purinergic receptors modulate MAP kinases and transcription factors that control microglial inflammatory gene expression. Neurochem. Int. 49 (2006) 204-214
35. Panenka W., Jijon H., Herx L.M., Armstrong J.N., Feighan D., Wei T., Yong V.W., Ransohoff R.M., and MacVicar B.A. P2X7-like receptor activation in astrocytes increases chemokine monocyte chemoattractant protein-1 expression via mitogen-activated protein kinase. J. Neurosci. 21 (2001) 7135-7142
36. Pfeiffer Z.A., Aga M., Prabhu U., Watters J.J., Hall D.J., and Bertics P.J. The nucleotide receptor P2X7 mediates actin reorganization and membrane blebbing in RAW 264.7 macrophages via p38 MAP kinase and Rho. J. Leukoc. Biol. 75 (2004) 1173-1182
37. Rampe D., Wang L., and Ringheim G.E. P2X7 receptor modulation of beta-amyloid- and LPS-induced cytokine secretion from human macrophages and microglia. J. Neuroimmunol. 147 (2004) 56-61
38. Rincón M., Flavell R.A., and Davis R.A. The JNK and P38 MAP kinase signaling pathways in T cell-mediated immune responses. Free Radic. Biol. Med. 28 (2000) 1328-1337
39. Sergeeva M., Strokin M., Wang H., Ubl J.J., and Reiser G. Arachidonic acid in astrocytes blocks Ca(2+) oscillations by inhibiting store-operated Ca(2+) entry, and causes delayed Ca(2+) influx. Cell Calcium 33 (2003) 283-292
40. Smart M.L., Gu B., Panchal R.G., Wiley J., Cromer B., Williams D.A., and Petrou S. P2X7 receptor cell surface expression and cytolytic pore formation are regulated by a distal C-terminal region. J. Biol. Chem. 278 (2003) 8853-8860
41. 2+ signaling. J. Neurosci. 26 (2006) 1378-1385
42. Su B., and Karin M. Mitogen-activated protein kinase cascades and regulation of gene expression. Curr. Opin. Immunol. 8 (1996) 402-411
43. Surprenant A., Rassendren F., Kawashima E., North R.A., and Buell G. The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science 272 (1996) 735-738
44. 2+ influx, pore formation and p44/42 MAP kinase phosphorylation mediated by P2X7 receptor activation in mouse microglial cells. J. Neurochem. 102 (2007) 1518-1532
45. 2 activation in primary afferent sensory neurons contributes to neuropathic pain. J. Neurochem. 103 (2007) 1408-1416
46. Virginio C., MacKenzie A., North R.A., and Surprenant A. Kinetics of cell lysis, dye uptake and permeability changes in cells expressing the rat P2X7 receptor. J. Physiol. 519 (1999) 335-346
47. Wilson H.L., Wilson S.A., Surprenant A., and North R.A. Epithelial membrane proteins induce membrane blebbing and interact with the P2X7 receptor C terminus. J. Biol. Chem. 277 (2002) 34017-34023